Simona Sciacchitano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simona Sciacchitano has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Alba Maria Pozo-Prados
1 shared publicationAna Izquierdo
1 shared publicationCarolina Fajardo
1 shared publication- Christian Napoli
Department of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication Eduardo Delgado Parada
1 shared publication- Eduardo Delgado-Parada
Department of Psychiatry, Hospital Universitario de La Princesa, 28006 Madrid, Spain
1 shared publication
Latest Publications
- 3 September 2026
- Published by Elsevier in Psiquiatría Biológica
- Vol. 33 (4)
Ziconotide-induced delirium: A case report
- 3 September 2026
- Published by Elsevier in Psiquiatría Biológica
- Vol. 33 (4)
Ziconotide-induced delirium: A case report
- 18 November 2024
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 39 (1)
Has psychiatric emergency care changed after the COVID-19 pandemic? A retrospective study in a tertiary hospital in Madrid, Spain
- 18 November 2024
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 39 (1)
Has psychiatric emergency care changed after the COVID-19 pandemic? A retrospective study in a tertiary hospital in Madrid, Spain
- Top Cited PapersOpen Access
- 26 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (3) , 721
To Be Frail or Not to Be Frail: This Is the Question—A Critical Narrative Review of Frailty
Many factors have contributed to rendering frailty an emerging, relevant, and very popular concept. First, many pandemics that have affected humanity in history, including COVID-19, most recently, have had more severe effects on frail people compared to non-frail ones. Second, the increase in human life expectancy observed in many developed countries, including Italy has led to a rise in the percentage of the older population that is more likely to be frail, which is why frailty is much a more common concern among geriatricians compared to other the various health-care professionals. Third, the stratification of people according to the occurrence and the degree of frailty allows healthcare decision makers to adequately plan for the allocation of available human professional and economic resources. Since frailty is considered to be fully preventable, there are relevant consequences in terms of potential benefits both in terms of the clinical outcome and healthcare costs. Frailty is becoming a popular, pervasive, and almost omnipresent concept in many different contexts, including clinical medicine, physical health, lifestyle behavior, mental health, health policy, and socio-economic planning sciences. The emergence of the new “science of frailty” has been recently acknowledged. However, there is still debate on the exact definition of frailty, the pathogenic mechanisms involved, the most appropriate method to assess frailty, and consequently, who should be considered frail. This narrative review aims to analyze frailty from many different aspects and points of view, with a special focus on the proposed pathogenic mechanisms, the various factors that have been considered in the assessment of frailty, and the emerging role of biomarkers in the early recognition of frailty, particularly on the role of mitochondria. According to the extensive literature on this topic, it is clear that frailty is a very complex syndrome, involving many different domains and affecting multiple physiological systems. Therefore, its management should be directed towards a comprehensive and multifaceted holistic approach and a personalized intervention strategy to slow down its progression or even to completely reverse the course of this condition.
- 26 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (3) , 721
Top Cited PapersOpen AccessTo Be Frail or Not to Be Frail: This Is the Question—A Critical Narrative Review of Frailty
Many factors have contributed to rendering frailty an emerging, relevant, and very popular concept. First, many pandemics that have affected humanity in history, including COVID-19, most recently, have had more severe effects on frail people compared to non-frail ones. Second, the increase in human life expectancy observed in many developed countries, including Italy has led to a rise in the percentage of the older population that is more likely to be frail, which is why frailty is much a more common concern among geriatricians compared to other the various health-care professionals. Third, the stratification of people according to the occurrence and the degree of frailty allows healthcare decision makers to adequately plan for the allocation of available human professional and economic resources. Since frailty is considered to be fully preventable, there are relevant consequences in terms of potential benefits both in terms of the clinical outcome and healthcare costs. Frailty is becoming a popular, pervasive, and almost omnipresent concept in many different contexts, including clinical medicine, physical health, lifestyle behavior, mental health, health policy, and socio-economic planning sciences. The emergence of the new “science of frailty” has been recently acknowledged. However, there is still debate on the exact definition of frailty, the pathogenic mechanisms involved, the most appropriate method to assess frailty, and consequently, who should be considered frail. This narrative review aims to analyze frailty from many different aspects and points of view, with a special focus on the proposed pathogenic mechanisms, the various factors that have been considered in the assessment of frailty, and the emerging role of biomarkers in the early recognition of frailty, particularly on the role of mitochondria. According to the extensive literature on this topic, it is clear that frailty is a very complex syndrome, involving many different domains and affecting multiple physiological systems. Therefore, its management should be directed towards a comprehensive and multifaceted holistic approach and a personalized intervention strategy to slow down its progression or even to completely reverse the course of this condition.